The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
(Adds details on Aetna business, compares with estimates)
Aug 7 (Reuters) - CVS Health Corp posted a better-than-expected quarterly profit on Wednesday, benefiting from higher sales in the Aetna health insurance business it acquired last year, and the company raised its full-year earnings forecast.
Shares of CVS rose 4% to $56.28 before the bell.
The company, which also runs drugstores and a pharmacy benefit management business, closed its $69 billion purchase of Aetna Inc in November.
CVS plans to bring more health services to its stores to tackle chronic conditions, one of the goals of combining the country's largest drugstore operator with one of the oldest health insurers.
Excluding items, CVS earned $1.89 per share, above the average analyst estimate of $1.69, according to IBES data from Refinitiv.
Operating costs rose 24.4% to $60.10 billion, as the company integrated Aetna into its operations.
CVS now expects full-year adjusted earnings per share of $6.89 to $7.00, compared with its previous forecast of $6.75 to $6.90.
The company reported net income of $1.94 billion, or $1.49 per share, for the second quarter ended June 30, compared with a loss of $2.56 billion, or $2.52 per share, a year earlier.
CVS had taken a $3.9 billion goodwill impairment charge related to its Omnicare business in the second quarter of 2018.
Total revenue rose 35.2% to $63.43 billion, ahead of estimates of $62.65 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)